Teleflex Medical OEM announces a significant expansion of its manufacturing infrastructure and production capabilities for bioresorbable sutures, fibers, and resins.

Wayne, PA   Teleflex Medical OEM, a global leader in medical suture and fiber technology, announces a significant expansion of its manufacturing infrastructure and production capabilities for bioresorbable sutures, fibers, and resins. The multi-million dollar investment at the Mansfield, Massachusetts facility includes expanded production and clean room areas, a new customer support center, and additional areas for research and development activities.


“The Mansfield expansion exemplifies our commitment to grow our operations in step with our customers' needs. The intent was to develop a specialized facility dedicated to our work in bioresorbable fiber and suture technology”, remarked Debra Masso, General Manager – Performance Fibers, Teleflex Medical OEM. “We certainly have achieved the goal with this state-of-the-art operation.”

An example of a bioresorbable product is Bondek® Plus (polyglycolic acid) coated suture. The suture holds body tissues together long enough to allow healing, but slowly resorbs over time so it does not leave foreign material or require additional surgical procedures for removal.

In addition to suture, the Mansfield facility will house manufacturing operations for specialized yarns of polyglycolic acid (PGA), poly-L-lactide (PLLA), and polyglycolic acid-co-poly-L-lactic acid (PGLA). These bioresorbable yarns can be knitted, woven, felted, or braided into bioresorbable components used in textile-based medical devices.

Teleflex Medical OEM is able to take a biomedical project from resin to fiber to yarn to component or suture. The company offers an extensive range of materials (both bioresorbable and non-absorbable), sizes (USP/EP and custom), and coatings to meet specific requirements for strength, flexibility, and handling. In addition, Teleflex Medical OEM is able to customize PIC counts and braids to allow the design of advanced custom constructs.

To learn more about Teleflex Medical OEM’s suture and fiber capabilities, visit


About Teleflex Incorporated

Teleflex is a leading global provider of specialty medical devices for a range of procedures in critical care and surgery. Our mission is to provide solutions that enable healthcare providers to improve outcomes and enhance patient and provider safety. Headquartered in Wayne, PA, Teleflex employs approximately 11,500 people worldwide and serves healthcare providers in more than 150 countries. Additional information about Teleflex can be obtained from the company's website at

Teleflex Medical OEM, division of Teleflex Incorporated, is known across the globe, for custom-engineered sutures and fibers, extrusions, diagnostic and interventional catheters, and sheath/dilator sets and kits.  Additional information about Teleflex Medical OEM can be obtained at

Forward-Looking Statements
Any statements contained in this press release that do not describe historical facts may constitute forward-looking statements. Any forward-looking statements contained herein are based on our management's current beliefs and expectations, but are subject to a number of risks, uncertainties and changes in circumstances, which may cause actual results or company actions to differ materially from what is expressed or implied by these statements. These risks and uncertainties are identified and described in more detail in our filings with the Securities and Exchange Commission, including our Annual Report on Form 10-K.

View website